Ascendis Pharma Q3 Adj. EPS $1.97 Beats $1.13 Estimate, Sales $425.432M Beat $417.230M Estimate
Benzinga Newsdesk 39 minutes ago
NewsEarningsEarnings Beats
Ascendis Pharma (NASDAQ:ASND) reported quarterly earnings of $1.97 per share which beat the analyst consensus estimate of $1.13 by 74.34 percent. This is a 328.26 percent increase over earnings of $0.46 per share from
Ascendis Pharma (NASDAQ:ASND) reported quarterly earnings of $1.97 per share which beat the analyst consensus estimate of $1.13 by 74.34 percent. This is a 328.26 percent increase over earnings of $0.46 per share from the same period last year. The company reported quarterly sales of $425.432 million which beat the analyst consensus estimate of $417.230 million by 1.97 percent. This is a 73.03 percent increase over sales of $245.868 million the same period last year.